Patritumab deruxtecan
Product Specifications
CAS Number
2227102-46-5
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Purity
>95.0%
Bioactivity
Patritumab deruxtecan (HER3-DXd) is an antibody-drug coupling (ADC) targeting HER3 consisting of a fully humanized anti-HER3 IgG1 monoclonal antibody linked via a cleavable tetrapeptide linker to a topoisomerase I inhibitor payload (an ezetiocan derivative, DXd) for the study of non-small cell lung cancer (NSCLC) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6448317-01 0.1 mL
PDXK (Pyridoxal Kinase, PKH, PNK, PRED79, C21orf97, HEL-S-1a, C21orf124) (PE)
Sign In for Pricing
View Details MBS6448317-02 5x 0.1 mL
PDXK (Pyridoxal Kinase, PKH, PNK, PRED79, C21orf97, HEL-S-1a, C21orf124) (PE)
Sign In for Pricing
View Details 
MBS036146-03 5x 96 Well
Mouse Cytohesin Interacting Protein ELISA Kit
Sign In for Pricing
View Details